Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer

NCT00006022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer
Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
DRUG: bryostatin 1

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]